| Autor: |
Christina M. Wray, Erica R. Thaler |
| Jazyk: |
angličtina |
| Rok vydání: |
2016 |
| Předmět: |
|
| Zdroj: |
World Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 2, Iss 4, Pp 230-233 (2016) |
| Druh dokumentu: |
article |
| ISSN: |
2095-8811 |
| DOI: |
10.1016/j.wjorl.2016.11.005 |
| Popis: |
Objective: To review the indications and clinical evidence supporting hypoglossal nerve stimulation (HNS) therapy for the treatment of moderate-to-severe obstructive sleep apnea (OSA). Methods: Peer reviewed literature on hypoglossal nerve stimulation therapy for obstructive sleep apnea from 2001 to 2016. Results: The only currently FDA-approved HNS device for the treatment of moderate-to-severe OSA is produced by Inspire Medical Systems, which recently published its 36-month outcomes data from its Stimulation Therapy for Apnea Reduction (STAR) trial. HNS therapy is currently indicated for moderate-to-severe OSA patients who are CPAP-intolerant, have a body mass index |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text